945 related articles for article (PubMed ID: 32619460)
1. TP63, SOX2, and KLF5 Establish a Core Regulatory Circuitry That Controls Epigenetic and Transcription Patterns in Esophageal Squamous Cell Carcinoma Cell Lines.
Jiang YY; Jiang Y; Li CQ; Zhang Y; Dakle P; Kaur H; Deng JW; Lin RY; Han L; Xie JJ; Yan Y; Doan N; Zheng Y; Mayakonda A; Hazawa M; Xu L; Li Y; Aswad L; Jeitany M; Kanojia D; Guan XY; Said JW; Yang W; Fullwood MJ; Lin DC; Koeffler HP
Gastroenterology; 2020 Oct; 159(4):1311-1327.e19. PubMed ID: 32619460
[TBL] [Abstract][Full Text] [Related]
2. Super-Enhancer-Driven Long Non-Coding RNA LINC01503, Regulated by TP63, Is Over-Expressed and Oncogenic in Squamous Cell Carcinoma.
Xie JJ; Jiang YY; Jiang Y; Li CQ; Lim MC; An O; Mayakonda A; Ding LW; Long L; Sun C; Lin LH; Chen L; Wu JY; Wu ZY; Cao Q; Fang WK; Yang W; Soukiasian H; Meltzer SJ; Yang H; Fullwood M; Xu LY; Li EM; Lin DC; Koeffler HP
Gastroenterology; 2018 Jun; 154(8):2137-2151.e1. PubMed ID: 29454790
[TBL] [Abstract][Full Text] [Related]
3. Reprogramming of the esophageal squamous carcinoma epigenome by SOX2 promotes ADAR1 dependence.
Wu Z; Zhou J; Zhang X; Zhang Z; Xie Y; Liu JB; Ho ZV; Panda A; Qiu X; Cejas P; Cañadas I; Akarca FG; McFarland JM; Nagaraja AK; Goss LB; Kesten N; Si L; Lim K; Liu Y; Zhang Y; Baek JY; Liu Y; Patil DT; Katz JP; Hai J; Bao C; Stachler M; Qi J; Ishizuka JJ; Nakagawa H; Rustgi AK; Wong KK; Meyerson M; Barbie DA; Brown M; Long H; Bass AJ
Nat Genet; 2021 Jun; 53(6):881-894. PubMed ID: 33972779
[TBL] [Abstract][Full Text] [Related]
4. Chlorogenic acid inhibits esophageal squamous cell carcinoma growth in vitro and in vivo by downregulating the expression of BMI1 and SOX2.
Zhan Y; Li R; Feng C; Li X; Huang S; Wang L; Liu Z; Jiang J; Han Y
Biomed Pharmacother; 2020 Jan; 121():109602. PubMed ID: 31707349
[TBL] [Abstract][Full Text] [Related]
5. Master transcription factors form interconnected circuitry and orchestrate transcriptional networks in oesophageal adenocarcinoma.
Chen L; Huang M; Plummer J; Pan J; Jiang YY; Yang Q; Silva TC; Gull N; Chen S; Ding LW; An O; Yang H; Cheng Y; Said JW; Doan N; Dinjens WN; Waters KM; Tuli R; Gayther SA; Klempner SJ; Berman BP; Meltzer SJ; Lin DC; Koeffler HP
Gut; 2020 Apr; 69(4):630-640. PubMed ID: 31409603
[TBL] [Abstract][Full Text] [Related]
6. SOX2 antagonizes WWC1 to drive YAP1 activation in esophageal squamous cell carcinoma.
Chai Y; Li Q; Zhao H; Zhang Z; Yu X; Pang L; Liu Z; Zhao J; Wang L; Li F
Cancer Med; 2019 Nov; 8(16):7055-7064. PubMed ID: 31560173
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Exploration to Identify Predictive DNA Markers of ΔNp63/SOX2 in Drug Resistance in Human Esophageal Squamous Cell Carcinoma.
Ooizumi Y; Kojima K; Igarashi K; Tanaka Y; Harada H; Yokota K; Kaida T; Ishii S; Tanaka T; Yokoi K; Nishizawa N; Washio M; Ushiku H; Katoh H; Kosaka Y; Mieno H; Hosoda K; Watanabe M; Katada C; Hiki N; Yamashita K
Ann Surg Oncol; 2019 Dec; 26(13):4814-4825. PubMed ID: 31529309
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4.
Yang C; Shen S; Zheng X; Ye K; Ge H; Sun Y; Lu Y
FASEB J; 2020 May; 34(5):6055-6069. PubMed ID: 32239565
[TBL] [Abstract][Full Text] [Related]
9. AR-42: A Pan-HDAC Inhibitor with Antitumor and Antiangiogenic Activities in Esophageal Squamous Cell Carcinoma.
Zhu Y; Yuan T; Zhang Y; Shi J; Bai L; Duan X; Tong R; Zhong L
Drug Des Devel Ther; 2019; 13():4321-4330. PubMed ID: 31908417
[TBL] [Abstract][Full Text] [Related]
10. Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma.
Ma S; Bao JYJ; Kwan PS; Chan YP; Tong CM; Fu L; Zhang N; Tong AHY; Qin YR; Tsao SW; Chan KW; Lok S; Guan XY
Gastroenterology; 2012 Sep; 143(3):675-686.e12. PubMed ID: 22705009
[TBL] [Abstract][Full Text] [Related]
11. Co-activation of super-enhancer-driven CCAT1 by TP63 and SOX2 promotes squamous cancer progression.
Jiang Y; Jiang YY; Xie JJ; Mayakonda A; Hazawa M; Chen L; Xiao JF; Li CQ; Huang ML; Ding LW; Sun QY; Xu L; Kanojia D; Jeitany M; Deng JW; Liao LD; Soukiasian HJ; Berman BP; Hao JJ; Xu LY; Li EM; Wang MR; Bi XG; Lin DC; Koeffler HP
Nat Commun; 2018 Sep; 9(1):3619. PubMed ID: 30190462
[TBL] [Abstract][Full Text] [Related]
12. Romidepsin exhibits anti-esophageal squamous cell carcinoma activity through the DDIT4-mTORC1 pathway.
Xia WF; Zheng XL; Liu WY; Huang YT; Wen CJ; Zhou HH; Wu QC; Wu LX
Cancer Gene Ther; 2024 May; 31(5):778-789. PubMed ID: 38480975
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic silencing of ZNF132 mediated by methylation-sensitive Sp1 binding promotes cancer progression in esophageal squamous cell carcinoma.
Jiang D; He Z; Wang C; Zhou Y; Li F; Pu W; Zhang X; Feng X; Zhang M; Yecheng X; Xu Y; Jin L; Guo S; Wang J; Wang M
Cell Death Dis; 2018 Dec; 10(1):1. PubMed ID: 30578410
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine.
Ahrens TD; Timme S; Hoeppner J; Ostendorp J; Hembach S; Follo M; Hopt UT; Werner M; Busch H; Boerries M; Lassmann S
Epigenetics; 2015; 10(5):431-45. PubMed ID: 25923331
[TBL] [Abstract][Full Text] [Related]
15. Bromodomain protein BRDT directs ΔNp63 function and super-enhancer activity in a subset of esophageal squamous cell carcinomas.
Wang X; Kutschat AP; Yamada M; Prokakis E; Böttcher P; Tanaka K; Doki Y; Hamdan FH; Johnsen SA
Cell Death Differ; 2021 Jul; 28(7):2207-2220. PubMed ID: 33658703
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic induction of tumor stemness via the lipopolysaccharide-TET3-HOXB2 signaling axis in esophageal squamous cell carcinoma.
Xu F; Liu Z; Liu R; Lu C; Wang L; Mao W; Zhu Q; Shou H; Zhang K; Li Y; Chu Y; Gu J; Ge D
Cell Commun Signal; 2020 Feb; 18(1):17. PubMed ID: 32014008
[TBL] [Abstract][Full Text] [Related]
17. CstF64-Induced Shortening of the
Lin A; Ji P; Niu X; Zhao X; Chen Y; Liu W; Liu Y; Fan W; Sun Y; Miao C; Zhang S; Tan W; Lin D; Wagner EJ; Wu C
Cancer Res; 2021 Nov; 81(22):5638-5651. PubMed ID: 34607841
[TBL] [Abstract][Full Text] [Related]
18. KDM6B promotes ESCC cell proliferation and metastasis by facilitating C/EBPβ transcription.
Qin M; Han F; Wu J; Gao FX; Li Y; Yan DX; He XM; Long Y; Tang XP; Ren DL; Gao Y; Dai TY
BMC Cancer; 2021 May; 21(1):559. PubMed ID: 34001062
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.
Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY
Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231
[TBL] [Abstract][Full Text] [Related]
20. Aspirin enhances the therapeutic efficacy of cisplatin in oesophageal squamous cell carcinoma by inhibition of putative cancer stem cells.
Zou Z; Zheng W; Fan H; Deng G; Lu SH; Jiang W; Yu X
Br J Cancer; 2021 Sep; 125(6):826-838. PubMed ID: 34316020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
